175 related articles for article (PubMed ID: 35126958)
21. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H; Li Z; Tang Z; Li J; Lang X
J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
[TBL] [Abstract][Full Text] [Related]
22. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis.
Hou A; Zhang Y; Fan Y; Zheng Y; Zhou X; Liu H
Cancer Manag Res; 2020; 12():4209-4216. PubMed ID: 32581592
[TBL] [Abstract][Full Text] [Related]
24. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
Chen Z; Zhou J; Liu Y; Ni H; Zhou B
Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
[TBL] [Abstract][Full Text] [Related]
25. Roles of lncRNA MAGI2-AS3 in human cancers.
Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
Wang G; Li H; Hou Y
Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044
[TBL] [Abstract][Full Text] [Related]
27. Novel insights for lncRNA MAGI2-AS3 in solid tumors.
Xue C; Li G; Lu J; Luo J; Jia J
Biomed Pharmacother; 2021 May; 137():111429. PubMed ID: 33761624
[TBL] [Abstract][Full Text] [Related]
28. MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
Xu X; Yuan X; Ni J; Guo J; Gao Y; Yin W; Li F; Wei L; Zhang J
J Cell Physiol; 2021 Feb; 236(2):1116-1130. PubMed ID: 32730644
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of lncRNA HOXA-AS3 in cervical cancer by targeting miR-29a-3p and its regulatory effect on tumor progression.
Xu H; Tang Y; He C; Tian Y; Ni R
J Obstet Gynaecol Res; 2022 Oct; 48(10):2594-2602. PubMed ID: 35817473
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H
RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
[TBL] [Abstract][Full Text] [Related]
32. LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells.
Cui S; Liu Z; Tang B; Wang Z; Li B
BMC Musculoskelet Disord; 2020 Mar; 21(1):149. PubMed ID: 32143617
[TBL] [Abstract][Full Text] [Related]
33. LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2.
Fang G; Wang J; Sun X; Xu R; Zhao X; Shao L; Sun C; Wang Y
Ann Hepatol; 2020; 19(5):535-540. PubMed ID: 32546442
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.
He J; Zhou X; Li L; Han Z
Cancer Manag Res; 2020; 12():289-302. PubMed ID: 32021443
[TBL] [Abstract][Full Text] [Related]
35. LncRNA HOXC-AS3 overexpression inhibits TGF-β2-induced colorectal cancer cell migration and invasion by sponging miR-1269.
Zhang TT; Chen HP; Yu SY; Zhao SP
Hum Exp Toxicol; 2022; 41():9603271221093630. PubMed ID: 35537198
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract][Full Text] [Related]
37. MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.
Yang X; Wu S; Li X; Yin Y; Chen R
J Clin Lab Anal; 2020 Oct; 34(10):e23431. PubMed ID: 32533587
[TBL] [Abstract][Full Text] [Related]
38. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
[TBL] [Abstract][Full Text] [Related]
39. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
Gong J; Ma L; Peng C; Liu J
Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
[TBL] [Abstract][Full Text] [Related]
40. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Li D; Wang J; Zhang M; Hu X; She J; Qiu X; Zhang X; Xu L; Liu Y; Qin S
Mol Ther Nucleic Acids; 2020 Mar; 19():109-123. PubMed ID: 31837602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]